NZ215163A - 4-substituted androstendione derivatives, processes for their preparation, and pharmaceutical compositions - Google Patents

4-substituted androstendione derivatives, processes for their preparation, and pharmaceutical compositions

Info

Publication number
NZ215163A
NZ215163A NZ215163A NZ21516386A NZ215163A NZ 215163 A NZ215163 A NZ 215163A NZ 215163 A NZ215163 A NZ 215163A NZ 21516386 A NZ21516386 A NZ 21516386A NZ 215163 A NZ215163 A NZ 215163A
Authority
NZ
New Zealand
Prior art keywords
compound
formula
group
dione
hydrogen
Prior art date
Application number
NZ215163A
Other languages
English (en)
Inventor
F Faustini
Alessio R D
V Villa
Salle E Di
P Lombardi
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NZ215163A publication Critical patent/NZ215163A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027—Azides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NZ215163A 1985-02-15 1986-02-14 4-substituted androstendione derivatives, processes for their preparation, and pharmaceutical compositions NZ215163A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858503940A GB8503940D0 (en) 1985-02-15 1985-02-15 4-substituted androstendione derivatives

Publications (1)

Publication Number Publication Date
NZ215163A true NZ215163A (en) 1988-02-29

Family

ID=10574550

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215163A NZ215163A (en) 1985-02-15 1986-02-14 4-substituted androstendione derivatives, processes for their preparation, and pharmaceutical compositions

Country Status (28)

Country Link
US (1) US4757061A (enExample)
JP (1) JPS61189295A (enExample)
KR (1) KR930005994B1 (enExample)
AT (1) AT396239B (enExample)
AU (1) AU577667B2 (enExample)
BE (1) BE904226A (enExample)
CA (1) CA1319362C (enExample)
CH (1) CH669199A5 (enExample)
CZ (1) CZ413691A3 (enExample)
DE (1) DE3604179A1 (enExample)
DK (1) DK167221B1 (enExample)
ES (2) ES8706165A1 (enExample)
FI (1) FI84272C (enExample)
FR (1) FR2577556B1 (enExample)
GB (2) GB8503940D0 (enExample)
GR (1) GR860430B (enExample)
HK (1) HK94090A (enExample)
HU (1) HU194909B (enExample)
IE (1) IE58864B1 (enExample)
IT (1) IT1190335B (enExample)
MY (1) MY102038A (enExample)
NL (1) NL8600383A (enExample)
NZ (1) NZ215163A (enExample)
PT (1) PT82030B (enExample)
SE (2) SE468515B (enExample)
SG (1) SG80890G (enExample)
SU (1) SU1574178A3 (enExample)
ZA (1) ZA861118B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8622330D0 (en) * 1986-09-17 1986-10-22 Erba Farmitalia 4-substituted 6-alkylidenandrostene-3,17-dione derivatives
GB8624251D0 (en) * 1986-10-09 1986-11-12 Erba Farmitalia "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives
DE3711772A1 (de) * 1987-04-08 1988-10-27 Schering Ag 4- und 15-disubstituierte 4-androsten-3,17-dione und verfahren zu deren herstellung
GB8711579D0 (en) * 1987-05-15 1987-06-17 Erba Farmitalia 4-amino-androstenedione derivatives
US5595985A (en) 1989-03-10 1997-01-21 Endorecherche Inc. Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia
CA2062973C (en) * 1989-07-07 2003-09-23 Fernand Labrie Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia
US5143909A (en) * 1991-03-19 1992-09-01 Merrell Dow Pharmaceuticals Inc. Aminosteroids in a method for inhibiting c17-20 lyase
US5120840A (en) * 1990-08-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. 4-amino-4-ene-steroids and their use as 5α-reductase inhibitors
AU642757B2 (en) * 1990-08-01 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-amino-delta4, 6-steroids and their use as 5alpha-reductase inhibitors
NZ239142A (en) * 1990-08-01 1994-05-26 Merrell Dow Pharma 4-amino-delta-4-steroids; preparatory processes and pharmaceutical compositions
US5130424A (en) * 1990-08-01 1992-07-14 Merrell Dow Pharmaceuticals Inc. 4-amino-delta-4,6-steroids and their use as 5 alpha-reductase inhibitors
US5218110A (en) * 1990-08-01 1993-06-08 Merrell Dow Pharmaceuticals 4-amino-Δ4 -steroids and their use as 5α-reductase inhibitors
US5318961A (en) * 1990-08-01 1994-06-07 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4-steroids and their use as 5α-reductase inhibitors
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
US5189032A (en) * 1991-03-19 1993-02-23 Merrell Dow Pharmaceuticals Inc. 4-amino-Δ4,6 -steroids and their use as 5α-reductase inhibitors
CA2107102A1 (en) * 1991-03-28 1992-09-29 Naoyuki Koizumi Novel oxa- or azasteroid derivatives
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
GB9111260D0 (en) * 1991-05-24 1991-07-17 Erba Carlo Spa Process for the preparation of 4-amino-unsaturated androstanedione derivatives
GB9217035D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Androst-4-eno(4,5-b)pyrrole derivatives and process for their preparation
HU221191B1 (en) * 1992-09-30 2002-08-28 Teikoku Hormone Mfg Co Ltd 7-substituted oxasteroid compounds, process for their preparation and pharmaceutical compositions containing the same
JPH07506120A (ja) * 1993-02-18 1995-07-06 フアルマシア・エ・アツプジヨン・エツセ・ピー・アー フッ素化４−アミノアンドロスタジエノン誘導体及びその製造方法
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
GB2284605A (en) * 1993-12-09 1995-06-14 Erba Carlo Spa 6-or 7-substituted 4-aminoandrostadienone derivatives
CN1042540C (zh) * 1994-05-02 1999-03-17 默里尔药物公司 通过4－硝基－△4－3－酮甾类化合物制备4－氨基－△4－3－酮甾类化合物的方法
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7435757B2 (en) * 2004-07-02 2008-10-14 Schering Ag 2-substituted D-homo-estra-1,3,5(10)-trienes as inhibitors of 17β-hydroxy steroid dehydrogenase type 1

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1042291A (en) * 1961-11-08 1966-09-14 Organon Labor Ltd í¸-6ª‡-amino steroids and the preparation thereof
DE1203768B (de) * 1962-02-01 1965-10-28 Merck Ag E Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Testosteronreiheund Saeureadditionssalzen derselben
DK120154B (da) * 1968-02-29 1971-04-19 Schering Ag Fremgangsmåde til fremstilling af N-substituerede 4-amino-3-oxosteroid-4,6-diener af androstan- eller pregnanrækken eller deres ammoniumsalte.
DE1668690C3 (de) * 1968-02-29 1978-09-14 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von N-substituierten 4-Aminosteroiden der Androstan-Pregnan- und Cholestanreihe
US3780070A (en) * 1972-09-21 1973-12-18 Schering Corp 4-azido-17alpha-alkinyl-4-gonen-17beta-ol-3-ones and method for their preparation
CA1154008A (en) * 1979-05-02 1983-09-20 Thomas R. Blohm STEROID 5.alpha.-REDUCTASE INHIBITORS

Also Published As

Publication number Publication date
NL8600383A (nl) 1986-09-01
FI860672A0 (fi) 1986-02-13
PT82030B (pt) 1988-07-01
HK94090A (en) 1990-11-23
GB8503940D0 (en) 1985-03-20
ATA38886A (de) 1992-11-15
JPH0469638B2 (enExample) 1992-11-06
PT82030A (en) 1986-03-01
ES552052A0 (es) 1987-06-01
DK167221B1 (da) 1993-09-20
DK71486A (da) 1986-08-16
FR2577556A1 (fr) 1986-08-22
BE904226A (fr) 1986-08-14
AU5343386A (en) 1986-08-21
IE58864B1 (en) 1993-11-17
HU194909B (en) 1988-03-28
IT8619361A0 (it) 1986-02-11
FI84272C (fi) 1991-11-11
FI860672A7 (fi) 1986-08-16
DK71486D0 (da) 1986-02-14
SG80890G (en) 1990-11-23
GB2171100B (en) 1988-11-30
AU577667B2 (en) 1988-09-29
CZ413691A3 (en) 1994-03-16
KR860006485A (ko) 1986-09-11
MY102038A (en) 1992-02-29
SE8600668L (sv) 1986-08-16
FI84272B (fi) 1991-07-31
JPS61189295A (ja) 1986-08-22
ES8708235A1 (es) 1987-10-01
ZA861118B (en) 1986-10-29
DE3604179A1 (de) 1986-08-21
CA1319362C (en) 1993-06-22
IT1190335B (it) 1988-02-16
SU1574178A3 (ru) 1990-06-23
CH669199A5 (de) 1989-02-28
US4757061A (en) 1988-07-12
GB8603265D0 (en) 1986-03-19
IE860413L (en) 1986-08-15
SE468515B (sv) 1993-02-01
SE8600668D0 (sv) 1986-02-14
IT8619361A1 (it) 1987-08-11
GR860430B (en) 1986-06-12
KR930005994B1 (ko) 1993-07-01
ES8706165A1 (es) 1987-06-01
FR2577556B1 (fr) 1988-01-08
HUT40454A (en) 1986-12-28
AT396239B (de) 1993-07-26
ES557215A0 (es) 1987-10-01
GB2171100A (en) 1986-08-20

Similar Documents

Publication Publication Date Title
CA1319362C (en) 4-substituted androstendione derivatives and process for their preparation
CS258498B2 (en) Method of androsta-1,4-dien-3,17-diones production
JP2000038341A (ja) ステロイドスルファタ―ゼインヒビタ―
PL175591B1 (pl) Środek farmaceutyczny do hamowania 5alfa-reduktazy testosteronowej
FI95804C (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 4-substituoituja 17 -(syklopropyyliamino)androst-5-eenijohdannaisia, jotka ovat hyödyllisiä C17-20-lyaasi-inhibiittoreina
JPH02243698A (ja) 性ステロイド活性を抑制するために用いるエストロゲン核誘導体の薬学組成物
JPH08510733A (ja) ４−アミノ−１７β−（シクロプロピロキシ）アンドロスト−４−エン−３−オン、４−アミノ−１７β−（シクロプロピルアミノ）アンドロスト−４−エン−３−オン及びＣ▲下１７−２０▼リアーゼ及び５α−レダクターゼ阻害剤としての関連する化合物類
EP0641205A1 (en) 17$g(a) AND 17$g(b) SUBSTITUTED ACYL 4 AZA STEROIDS
JPH01104096A (ja) １７−置換アンドロスタ−１，４−ジエン−３−オン誘導体
US5502044A (en) Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
JP3031585B2 (ja) Ｃ▲１７−２０▼リアーゼ抑制法におけるアミノステロイド類
US4771043A (en) Steroidic aromatase inhibitors
SK159994A3 (en) 17-alkylketone steroids useful as 5-alpha-reductase inhibitors
JP2000309599A (ja) エストラ−１，３，５（１０），１６−テトラエン誘導体
GB2185257A (en) 10 beta (-Alkynyl-4,9(11)-estradiene derivatives and process for their preparation
HUP0203655A2 (hu) Telítetlen 14,15-ciklopropano-androsztánok, előállításukat szolgáló eljárás és ezen vegyületeket tartalmazó gyógyszerészeti készítmények
WO1994010190A1 (en) 6,7α-DIFLUOROMETHYLENANDROSTA-1,4-DIEN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION